Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
08/2002
08/21/2002EP1233070A2 Method for producing L-glutamic acid
08/21/2002EP1233068A2 Method for producing L-glutamic acid
08/21/2002EP1233057A1 Sterilized microbial cells
08/21/2002EP1233023A1 Transcription factor and dna thereof
08/21/2002EP1232278A1 MICROBIAL 9$g(a)-HYDROXYLATION OF STEROIDS
08/21/2002EP1232270A1 IMPROVING DIDEOXYNUCLEOTIDE-TRIPHOSPHATE UTILIZATION BY THE HYPER-THERMOPHILIC DNA POLYMERASE FROM THE ARCHAEON i PYROCOCCUS FURIOSUS /i
08/21/2002EP1232269A1 Method for purifying proteins
08/21/2002EP1232268A2 Cytochrome p450 oxygenases and their uses
08/21/2002EP1232266A2 Polypeptides and nucleic acids encoding same
08/21/2002EP1232265A2 G-protein coupled receptor htogh35
08/21/2002EP1232264A2 Human fgf-21 gene and gene expression products
08/21/2002EP1232263A2 Polypeptides and nucleic acids encoding same
08/21/2002EP1232262A2 Recombinant gelatin in vaccines
08/21/2002EP1232261A2 Cloning and characterization of the cap gene promoter
08/21/2002EP1232250A2 Oleoyl-acyl-carrier-protein thioesterases in plants
08/21/2002EP1232244A2 Device for propagation and storage of microorganisms
08/21/2002EP1232182A2 Animal collagens and gelatins
08/21/2002EP1232181A2 Recombinant gelatins
08/21/2002EP1232180A1 Polypeptides derived from vitamin d nuclear receptor, and their uses in particular for screening vitamin d analogues
08/21/2002EP1232179A1 15 human secreted proteins
08/21/2002EP1232123A1 A biofuel cell using wastewater and active sludge for wastewater treatment
08/21/2002EP1231943A1 Interferon gamma conjugates
08/21/2002EP1231837A2 Preservation of sensitive biological material
08/21/2002EP0793729B1 Lyophilized bioluminescent bacterial reagent for the detection of toxicants
08/21/2002EP0746618B1 A method of preparing a variant of a lipolytic enzyme
08/21/2002EP0642580B1 Hepatocyte growth factor variants
08/21/2002EP0537160B1 Expression of recombinant hemoglobin in yeast
08/21/2002CN1365394A Novel process for producing L-epi-2-inosose and novel process for producing epi-inositol
08/21/2002CN1365393A Novel cytochrome p450 monooxygenases and their use for oxidizing organic compounds
08/21/2002CN1365392A Drosophila recombination-associated protein and methods for use
08/21/2002CN1365391A Mammalian cytokines and related reagents
08/21/2002CN1365389A MEG-3 protein
08/21/2002CN1365386A Engineering of metabolic control
08/21/2002CN1365385A Purple photosynthetic bacteria and health foods
08/21/2002CN1365284A Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
08/21/2002CN1364899A Mycose base hydrolase and its preparation and use
08/21/2002CN1364414A Changchuan mycin agricultural bactericide and its preparing method and use
08/21/2002CN1089250C Anti-cancer oral liquid contg. lipolytic enzyme
08/21/2002CN1089214C Yogourt
08/20/2002US6437219 Nucleic acids encoding sucrose-binding proteins
08/20/2002US6437218 Altered epicuticular wax
08/20/2002US6437116 Nucleic acid immunogens; lyme disease treatment, diagnosis, and vaccines
08/20/2002US6437110 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
08/20/2002US6437108 Essential bacterial genes and their use
08/20/2002US6437097 Mammalian pro-apoptotic Bok genes and their uses
08/20/2002US6437096 Diagnosing infections; vaccines; genetic engineering and expression
08/20/2002US6436903 Immunomodulating compounds comprising d-isomers of amino acids
08/20/2002US6436888 α-amylase mutants
08/20/2002US6436695 Yeast compositions for converting bio-available phosphorus in a culture medium to intracellular phosphorus
08/20/2002US6436694 Regulable gene expression in gram-positive bacteria
08/20/2002US6436691 Chemical compounds
08/20/2002US6436688 Isolated dna molecule having nucleotide sequence encoding polypeptide having specified amino acid sequence
08/20/2002US6436686 Isolated microtubule motor protein having microtubule stimulated adenosine triphosphatase activity and having greater than 90% amino acid sequence identity to specified sequence as measured using sequence comparison algorithm
08/20/2002US6436684 Isolated nucleic acid molecule consisting of selected nucleotide sequence encoding phenol sulfotransferase protein
08/20/2002US6436682 Isolated substantially purified gaussia, renilla mulleri or pleuromamma luciferase protein encoded by specified nucleotide sequences
08/20/2002US6436681 Method for producing biotin
08/20/2002US6436674 Recombinant dna containing dna encoding secretion signal which is more than 60% homologous to amino acid sequence of e. coli oppa secretion signal operatively linked to dna encoding human growth hormone having molecular weight of about 20,000
08/20/2002US6436672 Polynucleotides encoding a type V adenylyl cyclase
08/20/2002US6436664 Method for producing shikimic acid
08/20/2002US6436659 Biological indicator for sterilization processes with double buffer system
08/20/2002US6436643 Transforming mold cell containing restriction site for rare-cutting endonuclease in its chromosomal dna
08/20/2002US6436642 Method of classifying a thyroid carcinoma using differential gene expression
08/20/2002US6436410 DNA encoding neospora dihydrofolate reductase-thymidylate synthase
08/20/2002US6436409 Polynucleotide functionally coding for the LHP protein from Mycobacterium tuberculosis, its biologically active derivative fragments, as well as methods using the same
08/20/2002US6436396 Polypeptides having L-asparaginase activity
08/20/2002US6436395 Rosellinia subiculata ATCC 74386 and fungus ATCC 74387 for producing sordarin compounds for fungi control
08/20/2002CA2098404C Improved humanized immunoglobulins
08/20/2002CA2059124C Platelet aggregation inhibitors
08/20/2002CA2006865C Humanized immunoglobulins and their production and use
08/20/2002CA1341385C Mutation of human granulocyte colony stimulating factor to allow the addition of carbohydrate chains at novel positions
08/20/2002CA1341384C Expression and diagnostic use of gag encoded peptides which are immunologically reactive with antibodies to lav
08/19/2002CA2354197A1 Identification of nucleotide sequences specific for mycobacteria and development of differential diagnosis strategies for mycobacterial species
08/18/2002WO2002062966A1 Method of producing active dry yeast
08/15/2002WO2002063038A1 Method for identifying compounds modulating reverse cholesterol transport
08/15/2002WO2002063036A2 Vector system used in screening active substances
08/15/2002WO2002063027A1 Multi-sample fermentor and method of using same
08/15/2002WO2002063013A2 Human acid phosphatase gene
08/15/2002WO2002063012A2 Ragweed allergens
08/15/2002WO2002063010A2 Method of producing recombinant antibodies against tumors
08/15/2002WO2002063008A2 Intracellular signaling molecules
08/15/2002WO2002063007A2 TIMM8b-RELATED PROTEIN
08/15/2002WO2002063006A2 Receptors and membrane-associated proteins
08/15/2002WO2002063005A2 Lipid-associated molecules
08/15/2002WO2002063004A2 G-protein coupled receptors
08/15/2002WO2002063001A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
08/15/2002WO2002062999A2 Proteins and nucleic acids encoding same
08/15/2002WO2002062998A1 Novel protein and dna thereof
08/15/2002WO2002062997A1 Novel protein and use thereof
08/15/2002WO2002062996A1 Novel physiologically active peptide and use thereof
08/15/2002WO2002062995A2 Human dorsal root receptor-like g protein-coupled receptor
08/15/2002WO2002062985A1 A yeast with nk cell immunoregulatory activity as well as the preparing method and the uses thereof
08/15/2002WO2002062973A2 Lipase variants
08/15/2002WO2002062972A2 Hybridoma cell line g250 and its use for producing monoclonal antibodies
08/15/2002WO2002062959A2 Hepatitis b virus treatment
08/15/2002WO2002062945A2 Compositions and methods relating to lung specific genes and proteins
08/15/2002WO2002062841A2 Secreted proteins
08/15/2002WO2002062840A1 INTERFERON-α INDUCED GENE
08/15/2002WO2002062380A2 Chlamydia vaccine composition
08/15/2002WO2002062378A2 Hyperblebbing bacterial strains and use thereof for production of vaccines
08/15/2002WO2002062360A1 Endotoxin binding by lactic acid bacteria and bifidobacteria